Trends in the Treatment of Adults with Ureteropelvic Junction Obstruction by Jacobs, Bruce L. et al.
General Research
Trends in the Treatment of Adults
with Ureteropelvic Junction Obstruction
Bruce L. Jacobs, MD,1,2 Samuel R. Kaufman, MA,2 Hal Morgenstern, PhD,4
Brent K. Hollenbeck, MD, MS,1,2 J. Stuart Wolf, Jr., MD,3 and John M. Hollingsworth, MD, MS2,3
Abstract
Background and Purpose: Minimally invasive pyeloplasty is an effective treatment for patients with ureter-
opelvic junction obstruction that offers quicker convalescence than open pyeloplasty. Technical challenges,
however, may have limited its dissemination. We examined population trends and determinants of surgical
options for ureteropelvic junction obstruction.
Patients and Methods: Using the State Inpatient and Ambulatory Surgery Databases for Florida, we identified
adults who underwent ureteropelvic junction obstruction repair between 2001 and 2009. After determining the
surgical approach (minimally invasive pyeloplasty, open pyeloplasty, or endopyelotomy), we estimated annual
utilization rates and the effects of patient, surgeon, and hospital predictors on surgery type, using multilevel
multinomial logistic regression.
Results: Rates of minimally invasive pyeloplasty increased 360% (P for monotonic trend < 0.01), while rates of
open pyeloplasty decreased 56% (P < 0.01). Rates of endopyelotomy were substantially higher and remained
relatively stable (P= 0.27). Compared with open pyeloplasty, minimally invasive pyeloplasty was used more
commonly among patients with private insurance (odds ratio [OR] 1.6; 95% confidence interval [CI], 1.2–2.3),
those treated at teaching hospitals (OR 1.6; CI 1.0–2.6), and those treated by high-volume surgeons (OR 2.9; CI
2.0–4.2). Its use was less frequent among patients with multiple comorbidities (OR 0.53; CI 0.37–0.76). Similar
associations were observed when comparing receipt of minimally invasive pyeloplasty with endopyelotomy;
however, patients who underwent endopyelotomy were older.
Conclusions: The use of minimally invasive pyeloplasty has dramatically increased, largely replacing open
pyeloplasty, while the use of endopyelotomy, albeit significantly more common than the other approaches, has
remained stable. The surgical approach is influenced by several patient, surgeon, and hospital factors.
Introduction
Minimally invasive pyeloplasty is an effective treat-ment for patients with ureteropelvic junction obstruction
that offers quicker convalescence,1 decreased postoperative
pain,1,2 and improved cosmesis3 compared with the conven-
tional open pyeloplasty. With success rates greater than 90%,
minimally invasive pyeloplasty has equivalent outcomes to
those of open pyeloplasty4 and superior outcomes to those of
endopyelotomy.5
Despite these advantages, technical challenges may have
limited the uniform dissemination of minimally invasive
pyeloplasty. Laparoscopy has a steep learning curve, and
intracorporeal suturing is difficult.5,6 Formal laparoscopic
training is less prevalent in the urologic community, which
manifests as a lower utilization of minimally invasive pyelo-
plasties in this setting, compared with that in the academic
setting.6–8 Although the advent of robotic surgery has miti-
gated some of these challenges by reducing the learning
curve,5,9 its upfront expense (ie, capital investment of
$1 million–$2.25 million10) impedes its widespread adoption.
Previous studies demonstrate that minimally invasive tech-
niques for upper urinary tract procedures are influenced not
only by patient characteristics, but also by surgeon- and
hospital-level factors.11,12 The degree to which these factors
have affected the adoption of minimally invasive pyeloplasty
remains unclear, however.
For these reasons, we performed a study to characterize the
use of various treatments for ureteropelvic junction obstruc-
tion and identify patient, surgeon, and hospital determinants
Department of Urology, 1Divisions of Oncology, 2Health Services Research, and 3Endourology, University of Michigan, Ann Arbor,
Michigan.
4Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Abstract presented at the American Urological Association North Central Section Meeting, Chicago, USA, 2012.
JOURNAL OF ENDOUROLOGY
Volume 27, Number 3, March 2013
ª Mary Ann Liebert, Inc.
Pp. 355–360
DOI: 10.1089/end.2012.0017
355
of the surgical approach. In doing so, our analysis identifies
possible targets for intervention to hasten minimally invasive
pyeloplasty’s uptake in the community.
Patients and Methods
Data source and study population
We used the Healthcare Cost and Utilization Project’s State
Inpatient and Ambulatory Surgery Databases for Florida to
identify adults (18 years or older) who underwent uretero-
pelvic junction obstruction repair between 2001 and 2009.
These two databases provide patient-level discharge data for
100% of the patients from facilities in the state.13,14 Data from
Florida were chosen for two reasons. First, Florida is the
fourth most populous state15 and is racially and ethnically
diverse. Second, the Florida files capture the spectrum of
practice settings.16 Hospital characteristics were obtained by
linking these databases to the American Hospital Association
Survey, which contains an abundance of hospital-level data,
including information about teaching status and control or
ownership of the hospital (ie, hospital type).
We first identified inpatient procedures of interest (ie,
open pyeloplasty andminimally invasive pyeloplasty) using
International Classification of Diseases, 9th Revision, Clinical
Modification (ICD-9) procedure codes. Patients who un-
derwent a pyeloplasty during their hospital stay (ICD-9
55.87) were categorized as having an open pyeloplasty. To
account for the lack of a specific procedure code for mini-
mally invasive pyeloplasty, we applied a validated algo-
rithm17 to distinguish minimally invasive and open surgical
approaches. In addition, we used the nonspecific ICD-9 code
for laparoscopic robot-assisted procedure (17.42), which
became available in 2008. There was only one minimally
invasive pyeloplasty attributed to this ICD-9 code in 2008
and 26 in 2009, which alleviated concerns that this code
detected a significant number of minimally invasive pyelo-
plasties that would have otherwise gone unreported. Next,
we identified endopyelotomies in the State Ambulatory
Surgery Database using the Current Procedural Terminology,
4th Edition codes 50575, 52342, 52345, and 52346. Using
these criteria, our study population consisted of 565 mini-
mally invasive pyeloplasties, 850 open pyeloplasties, and
1841 endopyelotomies.
Outcomes
Our primary outcome was the surgical approach used for
ureteropelvic junction obstruction (ie, minimally invasive
pyeloplasty, open pyeloplasty, or endopyelotomy). We as-
sessed the associations between this outcome and several
patient, surgeon, and hospital characteristics. A teaching
hospital was defined as one that is a member of the Council of
Teaching Hospitals, has an Accreditation Council for Grad-
uate Medical Education approved residency program, or has
a ratio of full-time equivalent interns and residents to beds of
0.25 or higher.18 Hospital type was categorized as govern-
ment, nongovernment nonprofit, or nongovernment for-
profit. To determine surgeon volume for each patient, we
identified the number of ureteropelvic junction obstruction
procedures performed by the patient’s surgeon in the year of
the patient’s surgery. Surgeon volume was categorized into
three groups: Low (£ 2), intermediate (3–4), and high (‡ 5).
Statistical analysis
We estimated the annual rate of each surgical approach and
tested for monotonic trends using Poisson regression. Next, we
examined differences among patients who received minimally
invasive pyeloplasty vs those who received open pyeloplasty or
endopyelotomy, using chi-square tests. Specifically, we com-
pared a variety of demographic characteristics, urologist surgi-
cal volume, andproperties of the hospital atwhich patientswere
treated. The adjusted effects of these characteristics were esti-
mated using a multilevel multinomial logistic model,19 which
accounted for the three unordered categories (the surgical al-
ternatives) aswell as the nesting of patientswithin hospitals. The
model included covariates for age, sex, race, primary payer,
neighborhood socioeconomic status, comorbidity, hospital type,
hospital teaching status, surgeon volume, and year of treatment.
Neighborhood socioeconomic statuswas derived fromblock-
level census data onwealth, income, education, and occupation,
using the method of Diez Roux and associates.20 Comorbidity
wasmeasured by using the adaptation of the Charlson index by
Deyo and colleagues21 in which ICD-9 diagnosis and procedure
codes were used to note the presence or absence of 16 comorbid
conditions. All analyses were performed using SAS v9.2 (Cary,
NC). The probability of a type I error was set at 0.05, and all
testing was two-sided. The Institutional Review Board of the
University of Michigan approved the study protocol.
Results
From 2001 to 2009, rates of minimally invasive pyeloplasty
increased 360% (P for monotonic trend < 0.01), while those of
open pyeloplasty decreased 56% (P < 0.01) (Fig. 1). By 2008,
rates of minimally invasive pyeloplasty surpassed open
pyeloplasty. Throughout the study, rates of endopyelotomy
were substantially higher than those of both minimally in-
vasive pyeloplasty and open pyeloplasty; however, they re-
mained relatively stable (P = 0.27). Similarly, the rates of all
three surgeries combined remained stable throughout the
study period (P = 0.54).
There were significant case mix differences across the three
surgical approaches (Table 1). Compared with those under-
going open pyeloplasty or endopyelotomy, patients under-
going minimally invasive pyeloplasty were more frequently
younger, male, and nonwhite. Further, those treated with
minimally invasive pyeloplasty more often had private in-
surance, lived in higher socioeconomic status neighborhoods,
and had no comorbidities.
As with patient characteristics, hospital characteristics
differed among the three surgical approaches (Table 2).
Minimally invasive pyeloplasties were more frequently per-
formed in nongovernment, for-profit hospitals and in teach-
ing hospitals.
The frequency of procedure type by surgeon volume is il-
lustrated in Figure 2. The proportion of surgeries performed
by minimally invasive pyeloplasty was 43% for high-volume
surgeons, 14% for intermediate-volume surgeons, and 10%
for low-volume surgeons (P< 0.01). Among low- and
intermediate-volume surgeons, endopyelotomy was the pre-
dominant procedure.
Results from the multinomial logistic regression analysis
(Table 3) demonstrate that, compared with open pyeloplasty,
minimally invasive pyeloplasty was used more commonly
among patients with private insurance (odds ratio [OR] 1.6;
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95% confidence interval [CI], 1.2–2.3), those treated at teach-
ing hospitals (OR 1.6; 95% CI, 1.0–2.6), and those treated by
high-volume surgeons (OR 2.9; 95% CI, 2.0–4.2). Its use was
less frequent among patients with multiple comorbidities (OR
0.53; 95% CI, 0.37–0.76). Similar associations were observed
when comparing receipt of minimally invasive pyeloplasty to
endopyelotomy; however, patients who underwent en-
dopyelotomy tended to be older. By 2005, the odds of re-
ceiving a minimally invasive pyeloplasty, relative to either an
open pyeloplasty or endopyelotomy, was at least twofold
higher than in 2001 and continued to increase substantially
throughout the study period.
Discussion
Over the past decade, the use of minimally invasive pye-
loplasty has dramatically increased, largely replacing open
pyeloplasty, while the use of endopyelotomy, albeit signifi-
cantly more common than the other two approaches, has re-
mained relatively stable. The total rate of surgery for
ureteropelvic junction obstruction has remained stable during
this time. The surgical approach is influenced by several pa-
tient, provider, and hospital factors. We found that patients
with private insurance, patients treated by high-volume sur-
geons, and patients treated at teaching hospitals receive
minimally invasive pyeloplasties more frequently than either
open pyeloplasties or endopyelotomies.
Although the rate of minimally invasive pyeloplasty has
substantially increased, its dissemination varies, depending
on patient, surgeon, and hospital factors. Adjusting for other
covariates, patients undergoing minimally invasive pyelo-
plasty tended to be younger than patients undergoing en-
dopyelotomy. Although not as effective,5 endopyelotomy is
an attractive option for older patients who may benefit from
the least invasive approach.22 A more concerning finding,
however, is that patients with private insurance are more
FIG. 1. Trends in the treatment of ureteropelvic Junction obstruction. (A) Minimally invasive pyeloplasty; (B) open pye-
loplasty; (C) endopyelotomy; (D) total.
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likely than patients without private insurance to receive
minimally invasive pyeloplasties relative to open pyeloplas-
ties or endopyelotomies. This finding may stem from the in-
creasing number of robotic platforms in recent years23 and the
subsequent increase in the use of robot-assisted laparoscopic
pyeloplasties.24 Robotic equipment requires a substantial
initial investment.10 To recoup those costs, hospitals may
preferentially treat patients who have a favorable payer-mix
with this expensive technology. For instance, a single-
institutional study found that robot-assisted laparoscopic
prostatectomy was a money-losing proposition across all
payers, but it incurred the least debt when performed on
patients with private insurance.25 Alternatively, payer status
may relate to patient access to hospitals that provide new
technologies. In light of the advantages of minimally invasive
pyeloplasty, this disparity in utilization based on payer status
has quality-of-care implications for patients without private
insurance.
Along these same lines, the disproportionate use of mini-
mally invasive pyeloplasty by teaching hospitals has impli-
cations for patients as well. Our study supports previous
findings that physicians in academic settings are more likely
to perform minimally invasive pyeloplasties.6–8 In part, this
reflects the higher proportion of surgeons at academic centers
who are laparoscopically trained and the types of hospitals
investing in new, expensive technologies.8 The estimated ef-
fect of teaching vs a nonteaching hospital does not appear to
be explained by differences in surgeon volume.
Nonetheless, regardless of the setting, minimally invasive
pyeloplasties are performed primarily by high-volume sur-
geons. Forty-three percent of high-volume surgeons used the
minimally invasive approach, compared with only 14% and
10% of intermediate- and low-volume surgeons. This finding
underscores the technical demands and learning curve associ-
ated with minimally invasive pyeloplasty.5,6 Further, pyelo-
plasties are not common procedures, and surgeons who do not
see a large volume of these patientsmay be less inclined to learn
new and challenging techniques.26 At the same time, the ability
of robotic surgery to reduce the learning curve9 may help the
diffusion of minimally invasive pyeloplasties by attracting
lower-volume surgeons. Conversely, endopyelotomies repre-
sent the predominant procedure performed by lower volume
surgeons, largely because they are technically easier and less
morbid compared with pyeloplasties.22
These findings, along with endopyelotomy’s inferior suc-
cess rates to both open and minimally invasive pyeloplasty,22
suggest that endopyelotomy may be overused. Although
there is a definite role for endopyelotomies among a specific
patient population and for secondary repairs,27 64% of pa-
tients in our study were younger than 65 years, 80% had no
comorbidities, and the rates of endopyelotomy were often
twice as high as those for either of the pyeloplasty approaches.
Similarly, even though the rate of minimally invasive pyelo-
plasty has increased over the past 10 years, its utilization
compared with other treatments for ureteropelvic junction
obstruction appears to be affected by the patient’s primary
payer, the teaching status of the hospital, and the annual
number of cases performed by the surgeon.
These findings should be interpreted in the context of several
limitations. First, for the study period, patient information was
available only at the discharge level. Thus, we could not follow
patients over time and assess long-term outcomes. Further, the
context of the procedure (eg, a primary or secondary repair)
Table 1. Frequency Distributions (%) of Selected
Characteristics in Adult Patients, by Type
of Treatment for Ureteropelvic Junction Obstruction
Minimally
invasive
pyeloplasty
Open
pyeloplasty Endopyelotomy
Characteristic N = 565 N = 850 N = 1841
P
value
Patient age, years < 0.01
18–44 57 50 30
45–64 29 30 34
65 + 14 20 36
Sex 0.02
Female 55 61 61
Racea < 0.01
White 76 80 83
Nonwhite 24 20 17
Primary payerb < 0.01
Nonprivate 27 41 47
Private 73 59 53
Socioeconomic statusc < 0.01
Low 33 38 32
Medium 29 32 35
High 38 30 33
Comorbidity < 0.01
0 86 74 80
1 + 14 26 20
a35 patients with missing race.
b5 patients with missing primary payer.
c104 patients with missing socioeconomic status.
Table 2. Frequency Distribution (%) of Selected Hospital Characteristics for Adult Patients,
by Type of Treatment for Ureteropelvic Junction Obstruction
Minimally invasive
pyeloplasty Open pyeloplasty Endopyelotomy
Characteristics N = 565 N = 850 N = 1841 P value
Hospital typea 0.01
Government 17 14 13
Nongovernment, nonprofit 43 59 53
Nongovernment, for-profit 40 27 34
Teaching vs nonteaching hospitala 75 54 42 0.01
aIn all, 200 cases with missing hospital type and teaching status.
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could not be determined. Given the high success rates of both
minimally invasive5 and open pyeloplasties,28 however, the
number of secondary repairs (eg, endopyelotomies) will be
relatively low. Despite the inability to track patients longitudi-
nally, this study provides a population-based assessment of the
trends in treatment of ureteropelvic junction obstruction repair
and factors associated with surgical approach. Second, our
study is limited by the lack of a specific procedure code for
minimally invasive pyeloplasty. Given the advent of the robot-
assisted laparoscopic pyeloplasty at the turn of the century,
however, the simultaneous decline in the rate of open pyelo-
plasties, and the relative stability in the total number of proce-
dures, we believe our results accurately depict a substantial, yet
uneven, dissemination of minimally invasive pyeloplasty.
Third, we do not know the extent to which our findings from
Florida can be generalized to other states or the entire country.
Although Florida has a large, diverse population andnumerous
hospitals and ambulatory surgery centers, our findings will
need to be replicated in other populations.
Over the past decade, the rates of minimally invasive pye-
loplasty have risen dramatically, surpassing the rates of open
pyeloplasty. Reasons for this may include the improved
technical feasibility with robot-assisted surgery compared
with laparoscopy, the greater comfort in performing mini-
mally invasive pyeloplasties among the younger generation of
urologists, or the conviction that minimally invasive pyelo-
plasties produce better outcomes. Regardless of the reasons, its
dissemination is not occurring uniformly in the general pop-
ulation; minimally invasive pyeloplasties are performed more
frequently among patients with private insurance, those trea-
ted at teaching hospitals, and those cared for by high-volume
surgeons. Future studies are warranted to evaluate how the
expense of robotic technology, in particular, influences the
treatment pattern of minimally invasive pyeloplasty.
Conclusions
During the study period, the use of minimally invasive
pyeloplasty has dramatically increased, largely replacing
open pyeloplasty, while the use of endopyelotomy, albeit
significantly more common than the other two approaches,
has remained relatively stable. The total rate of surgery for
ureteropelvic junction obstruction has remained stable during
this time. The surgical approach is influenced by several pa-
tient, provider, and hospital factors.
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FIG. 2. Frequency distribution (%) of treatment for uretero-
pelvic junction obstruction, by the surgeon’s annual volume
of ureteropelvic junction obstruction procedures (low, £ 2;
inermediate, 3–4; and high, ‡ 5).
Table 3. Estimated Effect (Adjusted Odds Ratio*
and 95% Confidence Interval) of Each Predictor
on the Use of Minimally Invasive Pyeloplasty
vs Open Pyeloplasty or Endopyelotomy:
Results of a Multilevel, Multinomial
Logistic Regression Analysis
Predictor
Minimally invasive
pyeloplasty vs open
pyeloplasty
Minimally invasive
pyeloplasty
vs endopyelotomy
Patient age, years
18–44 1 1
45–64 0.93 (0.68–1.3) 0.45 (0.34–0.61)
65+ 1.2 (0.77–1.9) 0.35 (0.23–0.53)
Sex
Female 1 1
Male 1.3 (0.98–1.7) 1.2 (0.94–1.6)
Race
White 1 1
Nonwhite 0.76 (0.54–1.1) 0.83 (0.60–1.2)
Primary payer
Nonprivate 1 1
Private 1.6 (1.2–2.3) 1.5 (1.1–2.1)
Socioeconomic status
Low 1 1
Medium 1.1 (0.78–1.5) 0.87 (0.64–1.2)
High 1.1 (0.77–1.5) 0.85 (0.62–1.2)
Comorbidity
0 1 1
1+ 0.53 (0.37–0.76) 0.99 (0.70–1.4)
Hospital type
Government 1 1
Nongovernment,
nonprofit
0.54 (0.27–1.1) 0.66 (0.31–1.4)
Nongovernment,
for-profit
0.86 (0.42–1.8) 0.93 (0.43–2.0)
Teaching hospital
No 1 1
Yes 1.6 (1.0–2.6) 2.9 (1.7–4.8)
Surgeon volume
Low 1 1
Intermediate 1.6 (1.1–2.2) 1.6 (1.2–2.2)
High 2.9 (2.0–4.2) 2.5 (1.7–3.6)
Year
2001 1 1
2002 0.83 (0.39–1.7) 0.82 (0.39–1.7)
2003 1.1 (0.56–2.3) 0.93 (0.47–1.9)
2004 1.6 (0.81–3.2) 1.4 (0.70–2.7)
2005 2.3 (1.2–4.6) 2.6 (1.4–5.0)
2006 3.7 (1.9–7.1) 2.9 (1.5–5.3)
2007 3.0 (1.6–5.9) 2.9 (1.5–5.3)
2008 7.1 (3.7–14) 4.6 (2.5–8.3)
2009 14 (7.1–25) 9.1 (4.8–17)
*The effect of each predictor was adjusted for all other predictors
in the model.
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